Certain Genetic Alterations May Contribute to the Primary Resistance of Colorectal and Pancreatic Cancers to KRAS G12C Inhibitors
March 03, 2025
March 03, 2025
PHILADELPHIA, Pennsylvania, March 3 [Category: Medical] -- The American Association for Cancer Research posted the following news release:
* * *
Certain Genetic Alterations May Contribute to the Primary Resistance of Colorectal and Pancreatic Cancers to KRAS G12C Inhibitors
PHILADELPHIA - Colorectal cancer and pancreatic ductal adenocarcinoma that harbored the KRAS G12C mutation often carried other genetic alterations that can be associated with resistance . . .
* * *
Certain Genetic Alterations May Contribute to the Primary Resistance of Colorectal and Pancreatic Cancers to KRAS G12C Inhibitors
PHILADELPHIA - Colorectal cancer and pancreatic ductal adenocarcinoma that harbored the KRAS G12C mutation often carried other genetic alterations that can be associated with resistance . . .